VXRT vs. TCRX
VXRT (Vaxart, Inc.) and TCRX (TScan Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, VXRT returned -15.24%/yr vs -31.57%/yr for TCRX. At a 0.15 correlation, their price movements are largely independent.
Performance
VXRT vs. TCRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VXRT achieves a 54.45% return, which is significantly higher than TCRX's -13.49% return.
VXRT
- 1D
- -2.90%
- 1M
- -17.03%
- YTD
- 54.45%
- 6M
- 49.61%
- 1Y
- -7.76%
- 3Y*
- -15.24%
- 5Y*
- -41.56%
- 10Y*
- —
TCRX
- 1D
- -5.97%
- 1M
- -18.39%
- YTD
- -13.49%
- 6M
- -3.97%
- 1Y
- -39.92%
- 3Y*
- -31.57%
- 5Y*
- —
- 10Y*
- —
VXRT vs. TCRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
VXRT Vaxart, Inc. | 54.45% | -47.68% | 15.59% | -40.39% | -84.67% | -10.68% |
TCRX TScan Therapeutics, Inc. | -13.49% | -67.11% | -47.86% | 276.13% | -65.56% | -62.50% |
Correlation
The correlation between VXRT and TCRX is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jul 16, 2021 | 0.15 |
Fundamentals
VXRT:
$129.57M
TCRX:
$112.39M
VXRT:
$0.16
TCRX:
-$0.96
VXRT:
0.49
TCRX:
13.77
VXRT:
1.38
TCRX:
1.16
VXRT:
$255.61M
TCRX:
$8.15M
VXRT:
$193.63M
TCRX:
$6.66M
VXRT:
$45.63M
TCRX:
-$129.32M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VXRT vs. TCRX — Risk / Return Rank
VXRT
TCRX
VXRT vs. TCRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vaxart, Inc. (VXRT) and TScan Therapeutics, Inc. (TCRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VXRT | TCRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.39 | ||
| Sortino ratioReturn per unit of downside risk | +0.86 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 0.97 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.17 | -0.60 | +0.44 |
| Martin ratioReturn relative to average drawdown | -0.28 | -0.87 | +0.59 |
Loading charts...
Drawdowns
VXRT vs. TCRX - Drawdown Comparison
The maximum VXRT drawdown since its inception was -98.71%, which is greater than TCRX's maximum drawdown of -93.71%. Use the drawdown chart below to compare losses from any high point for VXRT and TCRX.
Loading charts...
Drawdown Indicators
| VXRT | TCRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.71% | -93.71% | -5.00% |
Max Drawdown (1Y)Largest decline over 1 year | -46.47% | -66.35% | +19.88% |
Max Drawdown (3Y)Largest decline over 3 years | -78.72% | -91.08% | +12.36% |
Max Drawdown (5Y)Largest decline over 5 years | -96.94% | — | — |
Current DrawdownCurrent decline from peak | -97.71% | -93.58% | -4.13% |
Average DrawdownAverage peak-to-trough decline | -82.98% | -72.14% | -10.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.23% | 46.18% | -16.95% |
Volatility
VXRT vs. TCRX - Volatility Comparison
The current volatility for Vaxart, Inc. (VXRT) is 16.55%, while TScan Therapeutics, Inc. (TCRX) has a volatility of 19.64%. This indicates that VXRT experiences smaller price fluctuations and is considered to be less risky than TCRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VXRT | TCRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.55% | 19.64% | -3.09% |
Volatility (6M)Calculated over the trailing 6-month period | 76.89% | 50.85% | +26.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 97.84% | 86.04% | +11.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 92.40% | 98.14% | -5.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 128.51% | 98.14% | +30.37% |
Dividends
VXRT vs. TCRX - Dividend Comparison
Neither VXRT nor TCRX has paid dividends to shareholders.
Financials
VXRT vs. TCRX - Financials Comparison
This section allows you to compare key financial metrics between Vaxart, Inc. and TScan Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
VXRT and TCRX have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TCRX has higher volatility (19.64%) compared to VXRT (16.55%). In terms of maximum drawdown, VXRT dropped -98.71% vs TCRX's -93.71%.
VXRT currently has the higher Sharpe Ratio (-0.08 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VXRT and TCRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer